Quest Medical voluntarily recalled certain lots of its Myocardial Protection System (MPS) delivery sets on Oct. 28 after finding the products had a possible seal failure that could lead to blood loss in patients.

Major medical societies released updated guidelines on Oct. 21 regarding multivessel PCI and thrombus aspiration in patients with STEMI undergoing primary PCI.

Patients with coronary artery disease undergoing elective surgery for colorectal cancer had a long delay in the operation after receiving a stent, according to a Veterans Affairs analysis.

A long-term follow-up of patients who underwent cardiac surgery in Sweden found there was no association between red blood cell storage times and estimated mortality at 30 days, two years and 10 years.

The FDA approved the Sapien XT transcatheter heart valve on Oct. 15 for aortic valve-in-valve procedures.

Patients at high risk for bleeding who underwent PCI had better outcomes if they received a polymer-free umirolimus-coated stent compared with a bare-metal stent, according to a randomized, double blind trial.

After two years of follow up, patients with peripheral artery disease who received a drug-coated balloon had significantly higher primary patency and a significantly lower rate of clinically driven target lesion revascularization compared with patients who received conventional percutaneous transluminal angioplasty (PTA).

The lead author of a recent trial that led to an FDA notification of potential issues with bioprosthetic aortic valves reiterated that the findings related to neurologic events were preliminary and inconclusive.